Your browser doesn't support javascript.
loading
A randomized phase I comparative pharmacokinetic study comparing SB5 with reference adalimumab in healthy volunteers.
Shin, D; Lee, Y; Kim, H; Körnicke, T; Fuhr, R.
Affiliation
  • Shin D; Samsung Bioepis Co., Ltd, Incheon, Korea.
  • Lee Y; Samsung Bioepis Co., Ltd, Incheon, Korea.
  • Kim H; Samsung Bioepis Co., Ltd, Incheon, Korea.
  • Körnicke T; PAREXEL International GmbH, Berlin, Germany.
  • Fuhr R; PAREXEL International GmbH, Berlin, Germany.
J Clin Pharm Ther ; 42(6): 672-678, 2017 Dec.
Article in En | MEDLINE | ID: mdl-28675520
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biosimilar Pharmaceuticals / Adalimumab Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: J Clin Pharm Ther Journal subject: FARMACIA / TERAPEUTICA Year: 2017 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biosimilar Pharmaceuticals / Adalimumab Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: J Clin Pharm Ther Journal subject: FARMACIA / TERAPEUTICA Year: 2017 Document type: Article Country of publication: